Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS -- Ignore unavailable to you. Want to Upgrade?

To: aliveinsf who wrote (294)	7/17/1998 3:51:00 PM
From: Caveat Emptor	Respond to of 410

I don't disagree with you "aliveinsf", and I continue to point to the period of July 30,- January 5. A significant Executive selloff accured during this period. A. Smith - 35,00 Shares - CLose to 900,00 Value (dependant on the cost basis) J. Heffernan - 82,000 shares - Over 2.2 MIllion (dependant on the cost basis) David Fleming - 45,000 Shares - Over 1.1 Million (Dependant on the cost basis). The timing of the selloff strikes me. This profit taking accured in the 3 month period in which Genzyme Development Partners, LP was involved in a MAJOR shift of Partnership units to another offshore venture funding entity. The offshore entitiy (Bioroyalties/Pharmaceutical Partners) is controlled by the same partners as Paine Webber R+D Partners 11. CASH was paid for these Partnership Units, Limited Partners (and I assume General Partners were paid), yet the control remained in the same hands (different entity/same generals) I look at the "block" timing of this selloff, and Partnership Unit Shift from a possible "compensation" standpoint. I do not like this relationship between Paine Webber R+D Partners 11, Genzyme Development Partners, LP, and Certain Officers and Directors of the Company. The "open ended" Spinning Probe is drawing the line in the sand on this issue. intelico.com Also, take a look at the relationship (since 1989) further 13D Edgar Filing 11/17/97 Prompt- Type "BIOROYALTIES" and review Paine Webber R+D 11 10K. sec.gov Also, someone called me "Paranoid" recently on this message board. I have been involved with Investor Investigations for 10 years now, ALWAYS getting involved in a "Reactive" mode. Arbitrations, Class Actions, always when the money was gone, and the deed was already done.... I am now trying to education from a "proactive" posture. "Information is the Investors Advocate" CAVEAT EMPTOR